Including only PDCD1-CD274 as an inhibitor (purple lines; Figure S3) resulted in a poor fit to the number of CTLs counted inside the tumor, as well as the dynamics of PDCD1 and CD274 themselves. Here, CD274 is linked to neoplasm.